FDA 483 - Blue Chip Medical Products, Inc. - February 18, 2022

An FDA inspection of Blue Chip Medical Products, Inc. in Suffern, NY, revealed deficiencies in their quality system. The firm failed to maintain written Medical Device Reporting (MDR) procedures and lacked an electronic submission account. Additionally, critical standard operating procedures were not properly approved with dates and signatures from upper management.